MedTrace Logo

Investigational MRI Clinical Software and Hardware

NCT05215132 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2026-04-24

No results posted yet for this study

Summary

Patients and healthy volunteers will be scanned in order to test new sequences.

Conditions

  • Image, Body

Interventions

RADIATION

MRI

1.5T or 3T MRI scanner (Siemens Medical Systems)

DRUG

Gadavist 2Ml Solution for Injection

Arm 1 and Arm 3 subjects will undergo this intervention (Gadavist 2Ml solution)

Sponsors & Collaborators

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-19
Primary Completion
2028-01-31
Completion
2028-01-31
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05215132 on ClinicalTrials.gov